Detalhe da pesquisa
1.
An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
PLoS One
; 18(11): e0289183, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963142
2.
IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer.
Mol Cancer Ther
; 20(12): 2457-2468, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625505
3.
Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation.
Elife
; 92020 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329713